InvestorsHub Logo
Followers 11
Posts 3347
Boards Moderated 0
Alias Born 11/16/2013

Re: None

Friday, 12/13/2019 1:25:58 PM

Friday, December 13, 2019 1:25:58 PM

Post# of 3058
Vyondys 53 approval is great news, but can a $2.7B cap increase be
justified or sustained?

I'm thinking there will be a pullback before it moves higher again?








https://www.marketwatch.com/story/sareptas-surprise-fda-approval-for-rare-disease-drug-excites-investors-2019-12-13?siteid=yhoof2&yptr=yahoo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRPT News